ANTIBODY RESPONSE TO HIGH-DOSE TRIVALENT VS STANDARD-DOSE QUADRIVALENT INFLUENZA VACCINE IN PATIENTS WITH HIGH-RISK CARDIOVASCULAR DISEASE: THE INVESTED TRIAL

被引：0
|
作者：
Peikert, Alexander [1 ]
Claggett, Brian [1 ]
Udell, Jacob A. [1 ]
Joseph, Jacob [1 ]
Hegde, Sheila M. [1 ]
Mao, Lu [1 ]
Wang, Tuo [1 ]
Havighurst, Thomas [1 ]
Farkouh, Micheal [1 ]
Bhatt, Deepak L. [1 ]
Tattersall, Matthew C. [1 ]
Cooper, Lawton S. [1 ]
Solomon, Scott D. [1 ]
Vardeny, Orly [1 ]
机构：
[1] Brigham & Womens Hosp, Harvard Med Sch, Boston, MA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1473-223
引用
收藏
页码：2003 / 2003
页数：1
相关论文
共 50 条
  • [1] Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease A Randomized Clinical Trial
    Vardeny, Orly
    Kim, KyungMann
    Udell, Jacob A.
    Joseph, Jacob
    Desai, Akshay S.
    Farkouh, Michael E.
    Hegde, Sheila M.
    Hernandez, Adrian F.
    McGeer, Allison
    Talbot, H. Keipp
    Anand, Inder
    Bhatt, Deepak L.
    Cannon, Christopher P.
    DeMets, David
    Gaziano, J. Michael
    Goodman, Shaun G.
    Nichol, Kristin
    Tattersall, Matthew C.
    Temte, Jonathan L.
    Wittes, Janet
    Yancy, Clyde
    Claggett, Brian
    Chen, Yi
    Mao, Lu
    Havighurst, Thomas C.
    Cooper, Lawton S.
    Solomon, Scott D.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (01): : 39 - 49
  • [2] High Dose versus Standard Dose Influenza Vaccine in Patients With High Risk Cardiovascular Disease: Results From the Invested Trial
    Vardeny, Orly
    Kim, KyungMann
    Udell, Jacob A.
    Joseph, Jacob
    Hernandez, Adrian F.
    Talbot, H. Keipp
    Farkouh, Michael E.
    Cooper, Lawton S.
    Solomon, Scott
    CIRCULATION, 2020, 142 (24) : E474 - E474
  • [3] High-dose influenza vaccine to reduce clinical outcomes in high-risk cardiovascular patients: Rationale and design of the INVESTED trial
    Vardeny, Orly
    Udell, Jacob A.
    Joseph, Jacob
    Farkouh, Michael E.
    Hernandez, Adrian F.
    McGeer, Alison J.
    Talbot, H. Keipp
    Bhatt, Deepak L.
    Cannon, Christopher P.
    Goodman, Shaun G.
    Anand, Inder
    DeMets, David L.
    Temte, Jon
    Wittes, Janet
    Nichol, Kristin
    Yancy, Clyde W.
    Gaziano, J. Michael
    Cooper, Lawton S.
    Kim, KyungMann
    Solomon, Scott D.
    AMERICAN HEART JOURNAL, 2018, 202 : 97 - 103
  • [4] Gastrointestinal Events in High-Dose vs Standard-Dose Influenza Vaccine Recipients
    Talbot, H. Keipp
    Dunning, Andrew J.
    Robertson, Corwin A.
    Landolfi, Victoria A.
    Greenberg, David P.
    DiazGranados, Carlos A.
    OPEN FORUM INFECTIOUS DISEASES, 2018, 5 (06):
  • [5] High-Dose vs. Standard-Dose Influenza Vaccine and Cardiopulmonary Hospitalization or Mortality: Emulating the INVESTED Trial Using Insurance Claims Data
    Najafzadeh, Mehdi
    Shin, Hojin
    Schneeweiss, Sebastian
    Wang, Shirley V.
    Solomon, Scott D.
    Vardeny, Orly
    Patorno, Elisabetta
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 (01) : 126 - 134
  • [6] Cost-effectiveness of high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccine for older people in a country with high influenza vaccination rate
    Nham, Eliel
    Seong, Hye
    Hyun, Hakjun
    Yoon, Jin Gu
    Noh, Ji Yun
    Cheong, Hee Jin
    Kim, Woo Joo
    Kim, Eugene
    Choi, Leejung
    Lee, Jung-Min
    Song, Joon Young
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (03)
  • [7] Relative effectiveness of high-dose vs. standard-dose quadrivalent influenza vaccine in chronic kidney disease: a secondary analysis of the DANFLU-1 trial
    Bartholdy, K.
    Johansen, N. D.
    Janstrup, K. H.
    Modin, D.
    Nealon, J.
    Samson, S.
    Salamand, C.
    Loiacono, M. M.
    Jensen, A. M. R.
    Landler, N. E.
    Claggett, B. L.
    Solomon, S. D.
    Gislason, G. H.
    Koeber, L.
    Biering-Soerensen, T.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [8] In Reply to 'High-Dose Versus Standard-Dose Influenza Vaccine in Hemodialysis Patients'
    Butler, Anne M.
    Layton, J. Bradley
    Dharnidharka, Vikas R.
    McGrath, Leah J.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 75 (03) : 456 - 457
  • [9] IMPACT OF HIGH-DOSE VS STANDARD-DOSE INFLUENZA VACCINE ON RESPIRATORY HOSPITALIZATIONS AMONG ADULTS
    Bianchini, M.
    Wright, G. C.
    Anderson, H. D.
    Perraillon, M. C.
    Lindrooth, R. C.
    VALUE IN HEALTH, 2022, 25 (07) : S303 - S303
  • [10] High-dose versus standard-dose influenza vaccine and cardiopulmonary hospitalization or mortality: Emulating the INVESTED trial using insurance claims data
    Shin, Ho Jin
    Zadeh, Mehdi Najaf
    Schneeweiss, Sebastian
    Wang, Shirley V.
    Solomon, Scott
    Vardeny, Orly
    Patorno, Elisabetta
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 275 - 276
12345